P NATL ACAD SCI USA 润色咨询

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

出版年份:1915 年文章数:71052 投稿命中率: 开通期刊会员,数据随心看

出版周期:Weekly 自引率:2.9% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2189483, encodeId=09b12189483a7, content=文章卡在Quality Control Issue Identified这一步好久了,怎么办,是需要在哪里再次确认吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=01ad2432470, createdName=123bc054m90暂无昵称, createdTime=Mon Feb 26 16:39:30 CST 2024, time=2024-02-26, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1001186, encodeId=145f100118693, content=总体来说效率挺高<br>Stage Start Date<br>Under Review 2021-07-19<br>Under Editor Review 2021-07-18<br>Under Editorial Board Review 2021-07-14<br>Quality Control Review Completed 2021-07-14<br>Quality Control Issue Identified 2021-07-13<br>Quality Control Review Started 2021-07-11<br>Author Approved Submission 2021-07-11<br>Preliminary Manuscript Information Submitted 2021-07-11, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=261, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7e0d5546701, createdName=ms5000000115506285, createdTime=Tue Jul 20 16:32:52 CST 2021, time=2021-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2187425, encodeId=feaa218e42577, content=学到了很多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ac99145644, createdName=ms6000001790334235, createdTime=Thu Feb 15 16:29:17 CST 2024, time=2024-02-15, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1001685, encodeId=0b3a1001685f9, content=under Editorial Board Review 状态一个多月了,大家知道是什么情况吗??, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=354, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=291c5244117, createdName=147c8eeam09(暂无昵称), createdTime=Thu Jul 22 14:14:10 CST 2021, time=2021-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2146398, encodeId=c2b821463988d, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:发育<br>经验分享:一审更新了两次 under review 状态,有大牛知道是为什么吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=924e6386178, createdName=ms4000001367023473, createdTime=Wed Jul 05 09:01:28 CST 2023, time=2023-07-05, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2100484, encodeId=97062100484a7, content=请问大家under review后又经过Under Editor Review再到Pending Recommendation,这预示是拒稿还是可以修回啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b1275528993, createdName=ms3000000956234154, createdTime=Mon Nov 14 20:06:42 CST 2022, time=2022-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220274, encodeId=3e3212202e453, content=PNAS和EMBO J哪一个更好呢,更能当作代表作呢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=267, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a2211714800, createdName=slientwo, createdTime=Tue May 17 13:09:19 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226568, encodeId=3bc012265685c, content=听说这个杂志美国科学院院士推荐的paper容易发表,有木有认识的帮忙推荐, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=259, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a82b5450835, createdName=osmataku, createdTime=Wed Jun 15 11:33:07 CST 2022, time=2022-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926926, encodeId=9f2492692684, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向:医学;血液病<br>经验分享:我这篇文章先投了NC,直接被编辑拒稿。在心灰意冷的情况下,投到了PNAS上,结果不到一个星期编辑就返修了,就提了一些格式、标点、用词上的一些问题,然后很快就改好返稿。早上提交,晚上8点就进入review阶段……这中间又返修了一次,需要补数据……虽然过程很复杂,又遇难疫情不能回校补实验。延期返稿时间两次(合计两个月),好在返回去之后就没有经过太多修改,很快就接收了。第一篇以一作的身份发表在这种顶级刊物上,心情很激动。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=480, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/aeM8TD8ZHQ6TS3uJOTcOmVPib3vrKicfAibPzCmv7yqepmLObZI5SjcfnpS6c601gJib89Kz6H2Y8M90Pydg7XicfuQ/132, createdBy=baba5084756, createdName=ms279145567006567, createdTime=Wed Feb 24 19:47:13 CST 2021, time=2021-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228480, encodeId=232112284801e, content=请问under review中的概率大吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=239, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0e5b5549664, createdName=ms7000000308199462, createdTime=Fri Jun 24 18:02:39 CST 2022, time=2022-06-24, status=1, ipAttribution=)]
    2024-02-26 123bc054m90暂无昵称 来自山东省

    文章卡在Quality Control Issue Identified这一步好久了,怎么办,是需要在哪里再次确认吗

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2189483, encodeId=09b12189483a7, content=文章卡在Quality Control Issue Identified这一步好久了,怎么办,是需要在哪里再次确认吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=01ad2432470, createdName=123bc054m90暂无昵称, createdTime=Mon Feb 26 16:39:30 CST 2024, time=2024-02-26, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1001186, encodeId=145f100118693, content=总体来说效率挺高<br>Stage Start Date<br>Under Review 2021-07-19<br>Under Editor Review 2021-07-18<br>Under Editorial Board Review 2021-07-14<br>Quality Control Review Completed 2021-07-14<br>Quality Control Issue Identified 2021-07-13<br>Quality Control Review Started 2021-07-11<br>Author Approved Submission 2021-07-11<br>Preliminary Manuscript Information Submitted 2021-07-11, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=261, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7e0d5546701, createdName=ms5000000115506285, createdTime=Tue Jul 20 16:32:52 CST 2021, time=2021-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2187425, encodeId=feaa218e42577, content=学到了很多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ac99145644, createdName=ms6000001790334235, createdTime=Thu Feb 15 16:29:17 CST 2024, time=2024-02-15, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1001685, encodeId=0b3a1001685f9, content=under Editorial Board Review 状态一个多月了,大家知道是什么情况吗??, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=354, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=291c5244117, createdName=147c8eeam09(暂无昵称), createdTime=Thu Jul 22 14:14:10 CST 2021, time=2021-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2146398, encodeId=c2b821463988d, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:发育<br>经验分享:一审更新了两次 under review 状态,有大牛知道是为什么吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=924e6386178, createdName=ms4000001367023473, createdTime=Wed Jul 05 09:01:28 CST 2023, time=2023-07-05, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2100484, encodeId=97062100484a7, content=请问大家under review后又经过Under Editor Review再到Pending Recommendation,这预示是拒稿还是可以修回啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b1275528993, createdName=ms3000000956234154, createdTime=Mon Nov 14 20:06:42 CST 2022, time=2022-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220274, encodeId=3e3212202e453, content=PNAS和EMBO J哪一个更好呢,更能当作代表作呢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=267, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a2211714800, createdName=slientwo, createdTime=Tue May 17 13:09:19 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226568, encodeId=3bc012265685c, content=听说这个杂志美国科学院院士推荐的paper容易发表,有木有认识的帮忙推荐, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=259, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a82b5450835, createdName=osmataku, createdTime=Wed Jun 15 11:33:07 CST 2022, time=2022-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926926, encodeId=9f2492692684, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向:医学;血液病<br>经验分享:我这篇文章先投了NC,直接被编辑拒稿。在心灰意冷的情况下,投到了PNAS上,结果不到一个星期编辑就返修了,就提了一些格式、标点、用词上的一些问题,然后很快就改好返稿。早上提交,晚上8点就进入review阶段……这中间又返修了一次,需要补数据……虽然过程很复杂,又遇难疫情不能回校补实验。延期返稿时间两次(合计两个月),好在返回去之后就没有经过太多修改,很快就接收了。第一篇以一作的身份发表在这种顶级刊物上,心情很激动。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=480, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/aeM8TD8ZHQ6TS3uJOTcOmVPib3vrKicfAibPzCmv7yqepmLObZI5SjcfnpS6c601gJib89Kz6H2Y8M90Pydg7XicfuQ/132, createdBy=baba5084756, createdName=ms279145567006567, createdTime=Wed Feb 24 19:47:13 CST 2021, time=2021-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228480, encodeId=232112284801e, content=请问under review中的概率大吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=239, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0e5b5549664, createdName=ms7000000308199462, createdTime=Fri Jun 24 18:02:39 CST 2022, time=2022-06-24, status=1, ipAttribution=)]
    2021-07-20 ms5000000115506285

    总体来说效率挺高
    Stage Start Date
    Under Review 2021-07-19
    Under Editor Review 2021-07-18
    Under Editorial Board Review 2021-07-14
    Quality Control Review Completed 2021-07-14
    Quality Control Issue Identified 2021-07-13
    Quality Control Review Started 2021-07-11
    Author Approved Submission 2021-07-11
    Preliminary Manuscript Information Submitted 2021-07-11

    5

    展开5条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2189483, encodeId=09b12189483a7, content=文章卡在Quality Control Issue Identified这一步好久了,怎么办,是需要在哪里再次确认吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=01ad2432470, createdName=123bc054m90暂无昵称, createdTime=Mon Feb 26 16:39:30 CST 2024, time=2024-02-26, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1001186, encodeId=145f100118693, content=总体来说效率挺高<br>Stage Start Date<br>Under Review 2021-07-19<br>Under Editor Review 2021-07-18<br>Under Editorial Board Review 2021-07-14<br>Quality Control Review Completed 2021-07-14<br>Quality Control Issue Identified 2021-07-13<br>Quality Control Review Started 2021-07-11<br>Author Approved Submission 2021-07-11<br>Preliminary Manuscript Information Submitted 2021-07-11, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=261, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7e0d5546701, createdName=ms5000000115506285, createdTime=Tue Jul 20 16:32:52 CST 2021, time=2021-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2187425, encodeId=feaa218e42577, content=学到了很多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ac99145644, createdName=ms6000001790334235, createdTime=Thu Feb 15 16:29:17 CST 2024, time=2024-02-15, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1001685, encodeId=0b3a1001685f9, content=under Editorial Board Review 状态一个多月了,大家知道是什么情况吗??, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=354, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=291c5244117, createdName=147c8eeam09(暂无昵称), createdTime=Thu Jul 22 14:14:10 CST 2021, time=2021-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2146398, encodeId=c2b821463988d, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:发育<br>经验分享:一审更新了两次 under review 状态,有大牛知道是为什么吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=924e6386178, createdName=ms4000001367023473, createdTime=Wed Jul 05 09:01:28 CST 2023, time=2023-07-05, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2100484, encodeId=97062100484a7, content=请问大家under review后又经过Under Editor Review再到Pending Recommendation,这预示是拒稿还是可以修回啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b1275528993, createdName=ms3000000956234154, createdTime=Mon Nov 14 20:06:42 CST 2022, time=2022-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220274, encodeId=3e3212202e453, content=PNAS和EMBO J哪一个更好呢,更能当作代表作呢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=267, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a2211714800, createdName=slientwo, createdTime=Tue May 17 13:09:19 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226568, encodeId=3bc012265685c, content=听说这个杂志美国科学院院士推荐的paper容易发表,有木有认识的帮忙推荐, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=259, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a82b5450835, createdName=osmataku, createdTime=Wed Jun 15 11:33:07 CST 2022, time=2022-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926926, encodeId=9f2492692684, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向:医学;血液病<br>经验分享:我这篇文章先投了NC,直接被编辑拒稿。在心灰意冷的情况下,投到了PNAS上,结果不到一个星期编辑就返修了,就提了一些格式、标点、用词上的一些问题,然后很快就改好返稿。早上提交,晚上8点就进入review阶段……这中间又返修了一次,需要补数据……虽然过程很复杂,又遇难疫情不能回校补实验。延期返稿时间两次(合计两个月),好在返回去之后就没有经过太多修改,很快就接收了。第一篇以一作的身份发表在这种顶级刊物上,心情很激动。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=480, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/aeM8TD8ZHQ6TS3uJOTcOmVPib3vrKicfAibPzCmv7yqepmLObZI5SjcfnpS6c601gJib89Kz6H2Y8M90Pydg7XicfuQ/132, createdBy=baba5084756, createdName=ms279145567006567, createdTime=Wed Feb 24 19:47:13 CST 2021, time=2021-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228480, encodeId=232112284801e, content=请问under review中的概率大吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=239, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0e5b5549664, createdName=ms7000000308199462, createdTime=Fri Jun 24 18:02:39 CST 2022, time=2022-06-24, status=1, ipAttribution=)]
    2024-02-15 ms6000001790334235 来自重庆

    学到了很多

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2189483, encodeId=09b12189483a7, content=文章卡在Quality Control Issue Identified这一步好久了,怎么办,是需要在哪里再次确认吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=01ad2432470, createdName=123bc054m90暂无昵称, createdTime=Mon Feb 26 16:39:30 CST 2024, time=2024-02-26, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1001186, encodeId=145f100118693, content=总体来说效率挺高<br>Stage Start Date<br>Under Review 2021-07-19<br>Under Editor Review 2021-07-18<br>Under Editorial Board Review 2021-07-14<br>Quality Control Review Completed 2021-07-14<br>Quality Control Issue Identified 2021-07-13<br>Quality Control Review Started 2021-07-11<br>Author Approved Submission 2021-07-11<br>Preliminary Manuscript Information Submitted 2021-07-11, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=261, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7e0d5546701, createdName=ms5000000115506285, createdTime=Tue Jul 20 16:32:52 CST 2021, time=2021-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2187425, encodeId=feaa218e42577, content=学到了很多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ac99145644, createdName=ms6000001790334235, createdTime=Thu Feb 15 16:29:17 CST 2024, time=2024-02-15, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1001685, encodeId=0b3a1001685f9, content=under Editorial Board Review 状态一个多月了,大家知道是什么情况吗??, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=354, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=291c5244117, createdName=147c8eeam09(暂无昵称), createdTime=Thu Jul 22 14:14:10 CST 2021, time=2021-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2146398, encodeId=c2b821463988d, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:发育<br>经验分享:一审更新了两次 under review 状态,有大牛知道是为什么吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=924e6386178, createdName=ms4000001367023473, createdTime=Wed Jul 05 09:01:28 CST 2023, time=2023-07-05, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2100484, encodeId=97062100484a7, content=请问大家under review后又经过Under Editor Review再到Pending Recommendation,这预示是拒稿还是可以修回啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b1275528993, createdName=ms3000000956234154, createdTime=Mon Nov 14 20:06:42 CST 2022, time=2022-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220274, encodeId=3e3212202e453, content=PNAS和EMBO J哪一个更好呢,更能当作代表作呢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=267, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a2211714800, createdName=slientwo, createdTime=Tue May 17 13:09:19 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226568, encodeId=3bc012265685c, content=听说这个杂志美国科学院院士推荐的paper容易发表,有木有认识的帮忙推荐, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=259, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a82b5450835, createdName=osmataku, createdTime=Wed Jun 15 11:33:07 CST 2022, time=2022-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926926, encodeId=9f2492692684, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向:医学;血液病<br>经验分享:我这篇文章先投了NC,直接被编辑拒稿。在心灰意冷的情况下,投到了PNAS上,结果不到一个星期编辑就返修了,就提了一些格式、标点、用词上的一些问题,然后很快就改好返稿。早上提交,晚上8点就进入review阶段……这中间又返修了一次,需要补数据……虽然过程很复杂,又遇难疫情不能回校补实验。延期返稿时间两次(合计两个月),好在返回去之后就没有经过太多修改,很快就接收了。第一篇以一作的身份发表在这种顶级刊物上,心情很激动。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=480, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/aeM8TD8ZHQ6TS3uJOTcOmVPib3vrKicfAibPzCmv7yqepmLObZI5SjcfnpS6c601gJib89Kz6H2Y8M90Pydg7XicfuQ/132, createdBy=baba5084756, createdName=ms279145567006567, createdTime=Wed Feb 24 19:47:13 CST 2021, time=2021-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228480, encodeId=232112284801e, content=请问under review中的概率大吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=239, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0e5b5549664, createdName=ms7000000308199462, createdTime=Fri Jun 24 18:02:39 CST 2022, time=2022-06-24, status=1, ipAttribution=)]
    2021-07-22 147c8eeam09(暂无昵称)

    under Editorial Board Review 状态一个多月了,大家知道是什么情况吗??

    9

    展开9条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2189483, encodeId=09b12189483a7, content=文章卡在Quality Control Issue Identified这一步好久了,怎么办,是需要在哪里再次确认吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=01ad2432470, createdName=123bc054m90暂无昵称, createdTime=Mon Feb 26 16:39:30 CST 2024, time=2024-02-26, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1001186, encodeId=145f100118693, content=总体来说效率挺高<br>Stage Start Date<br>Under Review 2021-07-19<br>Under Editor Review 2021-07-18<br>Under Editorial Board Review 2021-07-14<br>Quality Control Review Completed 2021-07-14<br>Quality Control Issue Identified 2021-07-13<br>Quality Control Review Started 2021-07-11<br>Author Approved Submission 2021-07-11<br>Preliminary Manuscript Information Submitted 2021-07-11, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=261, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7e0d5546701, createdName=ms5000000115506285, createdTime=Tue Jul 20 16:32:52 CST 2021, time=2021-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2187425, encodeId=feaa218e42577, content=学到了很多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ac99145644, createdName=ms6000001790334235, createdTime=Thu Feb 15 16:29:17 CST 2024, time=2024-02-15, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1001685, encodeId=0b3a1001685f9, content=under Editorial Board Review 状态一个多月了,大家知道是什么情况吗??, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=354, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=291c5244117, createdName=147c8eeam09(暂无昵称), createdTime=Thu Jul 22 14:14:10 CST 2021, time=2021-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2146398, encodeId=c2b821463988d, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:发育<br>经验分享:一审更新了两次 under review 状态,有大牛知道是为什么吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=924e6386178, createdName=ms4000001367023473, createdTime=Wed Jul 05 09:01:28 CST 2023, time=2023-07-05, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2100484, encodeId=97062100484a7, content=请问大家under review后又经过Under Editor Review再到Pending Recommendation,这预示是拒稿还是可以修回啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b1275528993, createdName=ms3000000956234154, createdTime=Mon Nov 14 20:06:42 CST 2022, time=2022-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220274, encodeId=3e3212202e453, content=PNAS和EMBO J哪一个更好呢,更能当作代表作呢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=267, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a2211714800, createdName=slientwo, createdTime=Tue May 17 13:09:19 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226568, encodeId=3bc012265685c, content=听说这个杂志美国科学院院士推荐的paper容易发表,有木有认识的帮忙推荐, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=259, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a82b5450835, createdName=osmataku, createdTime=Wed Jun 15 11:33:07 CST 2022, time=2022-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926926, encodeId=9f2492692684, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向:医学;血液病<br>经验分享:我这篇文章先投了NC,直接被编辑拒稿。在心灰意冷的情况下,投到了PNAS上,结果不到一个星期编辑就返修了,就提了一些格式、标点、用词上的一些问题,然后很快就改好返稿。早上提交,晚上8点就进入review阶段……这中间又返修了一次,需要补数据……虽然过程很复杂,又遇难疫情不能回校补实验。延期返稿时间两次(合计两个月),好在返回去之后就没有经过太多修改,很快就接收了。第一篇以一作的身份发表在这种顶级刊物上,心情很激动。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=480, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/aeM8TD8ZHQ6TS3uJOTcOmVPib3vrKicfAibPzCmv7yqepmLObZI5SjcfnpS6c601gJib89Kz6H2Y8M90Pydg7XicfuQ/132, createdBy=baba5084756, createdName=ms279145567006567, createdTime=Wed Feb 24 19:47:13 CST 2021, time=2021-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228480, encodeId=232112284801e, content=请问under review中的概率大吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=239, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0e5b5549664, createdName=ms7000000308199462, createdTime=Fri Jun 24 18:02:39 CST 2022, time=2022-06-24, status=1, ipAttribution=)]
    2023-07-05 ms4000001367023473 来自山东省

    审稿速度:2.0 | 投稿命中率:25.0
    偏重的研究方向:发育
    经验分享:一审更新了两次 under review 状态,有大牛知道是为什么吗

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=2189483, encodeId=09b12189483a7, content=文章卡在Quality Control Issue Identified这一步好久了,怎么办,是需要在哪里再次确认吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=01ad2432470, createdName=123bc054m90暂无昵称, createdTime=Mon Feb 26 16:39:30 CST 2024, time=2024-02-26, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1001186, encodeId=145f100118693, content=总体来说效率挺高<br>Stage Start Date<br>Under Review 2021-07-19<br>Under Editor Review 2021-07-18<br>Under Editorial Board Review 2021-07-14<br>Quality Control Review Completed 2021-07-14<br>Quality Control Issue Identified 2021-07-13<br>Quality Control Review Started 2021-07-11<br>Author Approved Submission 2021-07-11<br>Preliminary Manuscript Information Submitted 2021-07-11, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=261, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7e0d5546701, createdName=ms5000000115506285, createdTime=Tue Jul 20 16:32:52 CST 2021, time=2021-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2187425, encodeId=feaa218e42577, content=学到了很多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ac99145644, createdName=ms6000001790334235, createdTime=Thu Feb 15 16:29:17 CST 2024, time=2024-02-15, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1001685, encodeId=0b3a1001685f9, content=under Editorial Board Review 状态一个多月了,大家知道是什么情况吗??, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=354, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=291c5244117, createdName=147c8eeam09(暂无昵称), createdTime=Thu Jul 22 14:14:10 CST 2021, time=2021-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2146398, encodeId=c2b821463988d, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:发育<br>经验分享:一审更新了两次 under review 状态,有大牛知道是为什么吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=924e6386178, createdName=ms4000001367023473, createdTime=Wed Jul 05 09:01:28 CST 2023, time=2023-07-05, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2100484, encodeId=97062100484a7, content=请问大家under review后又经过Under Editor Review再到Pending Recommendation,这预示是拒稿还是可以修回啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b1275528993, createdName=ms3000000956234154, createdTime=Mon Nov 14 20:06:42 CST 2022, time=2022-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220274, encodeId=3e3212202e453, content=PNAS和EMBO J哪一个更好呢,更能当作代表作呢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=267, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a2211714800, createdName=slientwo, createdTime=Tue May 17 13:09:19 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226568, encodeId=3bc012265685c, content=听说这个杂志美国科学院院士推荐的paper容易发表,有木有认识的帮忙推荐, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=259, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a82b5450835, createdName=osmataku, createdTime=Wed Jun 15 11:33:07 CST 2022, time=2022-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926926, encodeId=9f2492692684, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向:医学;血液病<br>经验分享:我这篇文章先投了NC,直接被编辑拒稿。在心灰意冷的情况下,投到了PNAS上,结果不到一个星期编辑就返修了,就提了一些格式、标点、用词上的一些问题,然后很快就改好返稿。早上提交,晚上8点就进入review阶段……这中间又返修了一次,需要补数据……虽然过程很复杂,又遇难疫情不能回校补实验。延期返稿时间两次(合计两个月),好在返回去之后就没有经过太多修改,很快就接收了。第一篇以一作的身份发表在这种顶级刊物上,心情很激动。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=480, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/aeM8TD8ZHQ6TS3uJOTcOmVPib3vrKicfAibPzCmv7yqepmLObZI5SjcfnpS6c601gJib89Kz6H2Y8M90Pydg7XicfuQ/132, createdBy=baba5084756, createdName=ms279145567006567, createdTime=Wed Feb 24 19:47:13 CST 2021, time=2021-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228480, encodeId=232112284801e, content=请问under review中的概率大吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=239, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0e5b5549664, createdName=ms7000000308199462, createdTime=Fri Jun 24 18:02:39 CST 2022, time=2022-06-24, status=1, ipAttribution=)]
    2022-11-14 ms3000000956234154

    请问大家under review后又经过Under Editor Review再到Pending Recommendation,这预示是拒稿还是可以修回啊?

    3

    展开3条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2189483, encodeId=09b12189483a7, content=文章卡在Quality Control Issue Identified这一步好久了,怎么办,是需要在哪里再次确认吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=01ad2432470, createdName=123bc054m90暂无昵称, createdTime=Mon Feb 26 16:39:30 CST 2024, time=2024-02-26, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1001186, encodeId=145f100118693, content=总体来说效率挺高<br>Stage Start Date<br>Under Review 2021-07-19<br>Under Editor Review 2021-07-18<br>Under Editorial Board Review 2021-07-14<br>Quality Control Review Completed 2021-07-14<br>Quality Control Issue Identified 2021-07-13<br>Quality Control Review Started 2021-07-11<br>Author Approved Submission 2021-07-11<br>Preliminary Manuscript Information Submitted 2021-07-11, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=261, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7e0d5546701, createdName=ms5000000115506285, createdTime=Tue Jul 20 16:32:52 CST 2021, time=2021-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2187425, encodeId=feaa218e42577, content=学到了很多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ac99145644, createdName=ms6000001790334235, createdTime=Thu Feb 15 16:29:17 CST 2024, time=2024-02-15, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1001685, encodeId=0b3a1001685f9, content=under Editorial Board Review 状态一个多月了,大家知道是什么情况吗??, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=354, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=291c5244117, createdName=147c8eeam09(暂无昵称), createdTime=Thu Jul 22 14:14:10 CST 2021, time=2021-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2146398, encodeId=c2b821463988d, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:发育<br>经验分享:一审更新了两次 under review 状态,有大牛知道是为什么吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=924e6386178, createdName=ms4000001367023473, createdTime=Wed Jul 05 09:01:28 CST 2023, time=2023-07-05, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2100484, encodeId=97062100484a7, content=请问大家under review后又经过Under Editor Review再到Pending Recommendation,这预示是拒稿还是可以修回啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b1275528993, createdName=ms3000000956234154, createdTime=Mon Nov 14 20:06:42 CST 2022, time=2022-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220274, encodeId=3e3212202e453, content=PNAS和EMBO J哪一个更好呢,更能当作代表作呢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=267, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a2211714800, createdName=slientwo, createdTime=Tue May 17 13:09:19 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226568, encodeId=3bc012265685c, content=听说这个杂志美国科学院院士推荐的paper容易发表,有木有认识的帮忙推荐, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=259, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a82b5450835, createdName=osmataku, createdTime=Wed Jun 15 11:33:07 CST 2022, time=2022-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926926, encodeId=9f2492692684, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向:医学;血液病<br>经验分享:我这篇文章先投了NC,直接被编辑拒稿。在心灰意冷的情况下,投到了PNAS上,结果不到一个星期编辑就返修了,就提了一些格式、标点、用词上的一些问题,然后很快就改好返稿。早上提交,晚上8点就进入review阶段……这中间又返修了一次,需要补数据……虽然过程很复杂,又遇难疫情不能回校补实验。延期返稿时间两次(合计两个月),好在返回去之后就没有经过太多修改,很快就接收了。第一篇以一作的身份发表在这种顶级刊物上,心情很激动。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=480, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/aeM8TD8ZHQ6TS3uJOTcOmVPib3vrKicfAibPzCmv7yqepmLObZI5SjcfnpS6c601gJib89Kz6H2Y8M90Pydg7XicfuQ/132, createdBy=baba5084756, createdName=ms279145567006567, createdTime=Wed Feb 24 19:47:13 CST 2021, time=2021-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228480, encodeId=232112284801e, content=请问under review中的概率大吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=239, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0e5b5549664, createdName=ms7000000308199462, createdTime=Fri Jun 24 18:02:39 CST 2022, time=2022-06-24, status=1, ipAttribution=)]
    2022-05-17 slientwo

    PNAS和EMBO J哪一个更好呢,更能当作代表作呢。

    3

    展开3条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2189483, encodeId=09b12189483a7, content=文章卡在Quality Control Issue Identified这一步好久了,怎么办,是需要在哪里再次确认吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=01ad2432470, createdName=123bc054m90暂无昵称, createdTime=Mon Feb 26 16:39:30 CST 2024, time=2024-02-26, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1001186, encodeId=145f100118693, content=总体来说效率挺高<br>Stage Start Date<br>Under Review 2021-07-19<br>Under Editor Review 2021-07-18<br>Under Editorial Board Review 2021-07-14<br>Quality Control Review Completed 2021-07-14<br>Quality Control Issue Identified 2021-07-13<br>Quality Control Review Started 2021-07-11<br>Author Approved Submission 2021-07-11<br>Preliminary Manuscript Information Submitted 2021-07-11, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=261, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7e0d5546701, createdName=ms5000000115506285, createdTime=Tue Jul 20 16:32:52 CST 2021, time=2021-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2187425, encodeId=feaa218e42577, content=学到了很多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ac99145644, createdName=ms6000001790334235, createdTime=Thu Feb 15 16:29:17 CST 2024, time=2024-02-15, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1001685, encodeId=0b3a1001685f9, content=under Editorial Board Review 状态一个多月了,大家知道是什么情况吗??, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=354, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=291c5244117, createdName=147c8eeam09(暂无昵称), createdTime=Thu Jul 22 14:14:10 CST 2021, time=2021-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2146398, encodeId=c2b821463988d, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:发育<br>经验分享:一审更新了两次 under review 状态,有大牛知道是为什么吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=924e6386178, createdName=ms4000001367023473, createdTime=Wed Jul 05 09:01:28 CST 2023, time=2023-07-05, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2100484, encodeId=97062100484a7, content=请问大家under review后又经过Under Editor Review再到Pending Recommendation,这预示是拒稿还是可以修回啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b1275528993, createdName=ms3000000956234154, createdTime=Mon Nov 14 20:06:42 CST 2022, time=2022-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220274, encodeId=3e3212202e453, content=PNAS和EMBO J哪一个更好呢,更能当作代表作呢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=267, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a2211714800, createdName=slientwo, createdTime=Tue May 17 13:09:19 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226568, encodeId=3bc012265685c, content=听说这个杂志美国科学院院士推荐的paper容易发表,有木有认识的帮忙推荐, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=259, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a82b5450835, createdName=osmataku, createdTime=Wed Jun 15 11:33:07 CST 2022, time=2022-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926926, encodeId=9f2492692684, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向:医学;血液病<br>经验分享:我这篇文章先投了NC,直接被编辑拒稿。在心灰意冷的情况下,投到了PNAS上,结果不到一个星期编辑就返修了,就提了一些格式、标点、用词上的一些问题,然后很快就改好返稿。早上提交,晚上8点就进入review阶段……这中间又返修了一次,需要补数据……虽然过程很复杂,又遇难疫情不能回校补实验。延期返稿时间两次(合计两个月),好在返回去之后就没有经过太多修改,很快就接收了。第一篇以一作的身份发表在这种顶级刊物上,心情很激动。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=480, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/aeM8TD8ZHQ6TS3uJOTcOmVPib3vrKicfAibPzCmv7yqepmLObZI5SjcfnpS6c601gJib89Kz6H2Y8M90Pydg7XicfuQ/132, createdBy=baba5084756, createdName=ms279145567006567, createdTime=Wed Feb 24 19:47:13 CST 2021, time=2021-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228480, encodeId=232112284801e, content=请问under review中的概率大吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=239, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0e5b5549664, createdName=ms7000000308199462, createdTime=Fri Jun 24 18:02:39 CST 2022, time=2022-06-24, status=1, ipAttribution=)]
    2022-06-15 osmataku

    听说这个杂志美国科学院院士推荐的paper容易发表,有木有认识的帮忙推荐

    1

    展开1条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2189483, encodeId=09b12189483a7, content=文章卡在Quality Control Issue Identified这一步好久了,怎么办,是需要在哪里再次确认吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=01ad2432470, createdName=123bc054m90暂无昵称, createdTime=Mon Feb 26 16:39:30 CST 2024, time=2024-02-26, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1001186, encodeId=145f100118693, content=总体来说效率挺高<br>Stage Start Date<br>Under Review 2021-07-19<br>Under Editor Review 2021-07-18<br>Under Editorial Board Review 2021-07-14<br>Quality Control Review Completed 2021-07-14<br>Quality Control Issue Identified 2021-07-13<br>Quality Control Review Started 2021-07-11<br>Author Approved Submission 2021-07-11<br>Preliminary Manuscript Information Submitted 2021-07-11, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=261, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7e0d5546701, createdName=ms5000000115506285, createdTime=Tue Jul 20 16:32:52 CST 2021, time=2021-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2187425, encodeId=feaa218e42577, content=学到了很多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ac99145644, createdName=ms6000001790334235, createdTime=Thu Feb 15 16:29:17 CST 2024, time=2024-02-15, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1001685, encodeId=0b3a1001685f9, content=under Editorial Board Review 状态一个多月了,大家知道是什么情况吗??, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=354, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=291c5244117, createdName=147c8eeam09(暂无昵称), createdTime=Thu Jul 22 14:14:10 CST 2021, time=2021-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2146398, encodeId=c2b821463988d, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:发育<br>经验分享:一审更新了两次 under review 状态,有大牛知道是为什么吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=924e6386178, createdName=ms4000001367023473, createdTime=Wed Jul 05 09:01:28 CST 2023, time=2023-07-05, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2100484, encodeId=97062100484a7, content=请问大家under review后又经过Under Editor Review再到Pending Recommendation,这预示是拒稿还是可以修回啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b1275528993, createdName=ms3000000956234154, createdTime=Mon Nov 14 20:06:42 CST 2022, time=2022-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220274, encodeId=3e3212202e453, content=PNAS和EMBO J哪一个更好呢,更能当作代表作呢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=267, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a2211714800, createdName=slientwo, createdTime=Tue May 17 13:09:19 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226568, encodeId=3bc012265685c, content=听说这个杂志美国科学院院士推荐的paper容易发表,有木有认识的帮忙推荐, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=259, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a82b5450835, createdName=osmataku, createdTime=Wed Jun 15 11:33:07 CST 2022, time=2022-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926926, encodeId=9f2492692684, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向:医学;血液病<br>经验分享:我这篇文章先投了NC,直接被编辑拒稿。在心灰意冷的情况下,投到了PNAS上,结果不到一个星期编辑就返修了,就提了一些格式、标点、用词上的一些问题,然后很快就改好返稿。早上提交,晚上8点就进入review阶段……这中间又返修了一次,需要补数据……虽然过程很复杂,又遇难疫情不能回校补实验。延期返稿时间两次(合计两个月),好在返回去之后就没有经过太多修改,很快就接收了。第一篇以一作的身份发表在这种顶级刊物上,心情很激动。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=480, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/aeM8TD8ZHQ6TS3uJOTcOmVPib3vrKicfAibPzCmv7yqepmLObZI5SjcfnpS6c601gJib89Kz6H2Y8M90Pydg7XicfuQ/132, createdBy=baba5084756, createdName=ms279145567006567, createdTime=Wed Feb 24 19:47:13 CST 2021, time=2021-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228480, encodeId=232112284801e, content=请问under review中的概率大吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=239, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0e5b5549664, createdName=ms7000000308199462, createdTime=Fri Jun 24 18:02:39 CST 2022, time=2022-06-24, status=1, ipAttribution=)]
    2021-02-24 ms279145567006567

    审稿速度:6.0 | 投稿命中率:25.0
    偏重的研究方向:医学;血液病
    经验分享:我这篇文章先投了NC,直接被编辑拒稿。在心灰意冷的情况下,投到了PNAS上,结果不到一个星期编辑就返修了,就提了一些格式、标点、用词上的一些问题,然后很快就改好返稿。早上提交,晚上8点就进入review阶段……这中间又返修了一次,需要补数据……虽然过程很复杂,又遇难疫情不能回校补实验。延期返稿时间两次(合计两个月),好在返回去之后就没有经过太多修改,很快就接收了。第一篇以一作的身份发表在这种顶级刊物上,心情很激动。

    4

    展开4条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=2189483, encodeId=09b12189483a7, content=文章卡在Quality Control Issue Identified这一步好久了,怎么办,是需要在哪里再次确认吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=01ad2432470, createdName=123bc054m90暂无昵称, createdTime=Mon Feb 26 16:39:30 CST 2024, time=2024-02-26, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1001186, encodeId=145f100118693, content=总体来说效率挺高<br>Stage Start Date<br>Under Review 2021-07-19<br>Under Editor Review 2021-07-18<br>Under Editorial Board Review 2021-07-14<br>Quality Control Review Completed 2021-07-14<br>Quality Control Issue Identified 2021-07-13<br>Quality Control Review Started 2021-07-11<br>Author Approved Submission 2021-07-11<br>Preliminary Manuscript Information Submitted 2021-07-11, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=261, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7e0d5546701, createdName=ms5000000115506285, createdTime=Tue Jul 20 16:32:52 CST 2021, time=2021-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2187425, encodeId=feaa218e42577, content=学到了很多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ac99145644, createdName=ms6000001790334235, createdTime=Thu Feb 15 16:29:17 CST 2024, time=2024-02-15, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1001685, encodeId=0b3a1001685f9, content=under Editorial Board Review 状态一个多月了,大家知道是什么情况吗??, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=354, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=291c5244117, createdName=147c8eeam09(暂无昵称), createdTime=Thu Jul 22 14:14:10 CST 2021, time=2021-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2146398, encodeId=c2b821463988d, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:发育<br>经验分享:一审更新了两次 under review 状态,有大牛知道是为什么吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=924e6386178, createdName=ms4000001367023473, createdTime=Wed Jul 05 09:01:28 CST 2023, time=2023-07-05, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2100484, encodeId=97062100484a7, content=请问大家under review后又经过Under Editor Review再到Pending Recommendation,这预示是拒稿还是可以修回啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b1275528993, createdName=ms3000000956234154, createdTime=Mon Nov 14 20:06:42 CST 2022, time=2022-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220274, encodeId=3e3212202e453, content=PNAS和EMBO J哪一个更好呢,更能当作代表作呢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=267, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a2211714800, createdName=slientwo, createdTime=Tue May 17 13:09:19 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226568, encodeId=3bc012265685c, content=听说这个杂志美国科学院院士推荐的paper容易发表,有木有认识的帮忙推荐, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=259, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a82b5450835, createdName=osmataku, createdTime=Wed Jun 15 11:33:07 CST 2022, time=2022-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926926, encodeId=9f2492692684, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向:医学;血液病<br>经验分享:我这篇文章先投了NC,直接被编辑拒稿。在心灰意冷的情况下,投到了PNAS上,结果不到一个星期编辑就返修了,就提了一些格式、标点、用词上的一些问题,然后很快就改好返稿。早上提交,晚上8点就进入review阶段……这中间又返修了一次,需要补数据……虽然过程很复杂,又遇难疫情不能回校补实验。延期返稿时间两次(合计两个月),好在返回去之后就没有经过太多修改,很快就接收了。第一篇以一作的身份发表在这种顶级刊物上,心情很激动。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=480, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/aeM8TD8ZHQ6TS3uJOTcOmVPib3vrKicfAibPzCmv7yqepmLObZI5SjcfnpS6c601gJib89Kz6H2Y8M90Pydg7XicfuQ/132, createdBy=baba5084756, createdName=ms279145567006567, createdTime=Wed Feb 24 19:47:13 CST 2021, time=2021-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228480, encodeId=232112284801e, content=请问under review中的概率大吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=239, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0e5b5549664, createdName=ms7000000308199462, createdTime=Fri Jun 24 18:02:39 CST 2022, time=2022-06-24, status=1, ipAttribution=)]
    2022-06-24 ms7000000308199462

    请问under review中的概率大吗?

    5

    展开5条回复
共181条页码: 1/19页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分